Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (8)

2023

  1. Selection of the best of 2022 in familial heart disease and cardiovascular genetics

    REC: CardioClinics, Vol. 58, pp. S68-S73

2022

  1. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198

  2. Selection of the best of 2021 in familial heart disease and cardiovascular genetics

    REC: CardioClinics, Vol. 57, pp. S54-S59

2021

  1. Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction

    Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662

2018

  1. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2457-2467

2012

  1. Nanopartículas derivadas de válvula aórtica: sin evidencias de vida

    Revista Espanola de Cardiologia, Vol. 65, Núm. 9, pp. 813-818

2010

  1. Variabilidad inter e intraobservador en la valoración ecocardiográfica de la función del ventrículo derecho

    Revista Espanola de Cardiologia, Vol. 63, Núm. 7, pp. 802-809

2008

  1. Rationale, design, and methods for the early surgery in infective endocarditis study (ENDOVAL 1): A multicenter, prospective, randomized trial comparing the state-of-the-art therapeutic strategy versus early surgery strategy in infective endocarditis

    American Heart Journal, Vol. 156, Núm. 3, pp. 431-436